Temozolomide treatment for pituitary aggressive tumours and pituitary carcinomas : initial results and long-term follow-up of a cohort of 32 cases
(2015) . 17th European Congress of Endocrinology; Endocrine Abstracts 2015, 37: GP30.01 — Location: Dublin
